Lupin Limited

NSEI:LUPIN Stock Report

Market Cap: ₹1.0t

Lupin Past Earnings Performance

Past criteria checks 5/6

Lupin has been growing earnings at an average annual rate of 39.4%, while the Pharmaceuticals industry saw earnings growing at 13.3% annually. Revenues have been growing at an average rate of 5.3% per year. Lupin's return on equity is 16.9%, and it has net margins of 12.3%.

Key information

39.4%

Earnings growth rate

39.3%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate5.3%
Return on equity16.9%
Net Margin12.3%
Next Earnings Update11 Feb 2025

Recent past performance updates

Recent updates

We Ran A Stock Scan For Earnings Growth And Lupin (NSE:LUPIN) Passed With Ease

Jan 03
We Ran A Stock Scan For Earnings Growth And Lupin (NSE:LUPIN) Passed With Ease

Lupin Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Nov 10
Lupin Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

With EPS Growth And More, Lupin (NSE:LUPIN) Makes An Interesting Case

Sep 17
With EPS Growth And More, Lupin (NSE:LUPIN) Makes An Interesting Case

Lupin Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 09
Lupin Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Unpleasant Surprises Could Be In Store For Lupin Limited's (NSE:LUPIN) Shares

Aug 01
Unpleasant Surprises Could Be In Store For Lupin Limited's (NSE:LUPIN) Shares

Lupin Limited (NSE:LUPIN) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Jul 13
Lupin Limited (NSE:LUPIN) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Lupin's (NSE:LUPIN) Dividend Will Be Increased To ₹8.00

Jul 12
Lupin's (NSE:LUPIN) Dividend Will Be Increased To ₹8.00

These 4 Measures Indicate That Lupin (NSE:LUPIN) Is Using Debt Safely

Jun 15
These 4 Measures Indicate That Lupin (NSE:LUPIN) Is Using Debt Safely

Analysts Are Updating Their Lupin Limited (NSE:LUPIN) Estimates After Its Annual Results

May 09
Analysts Are Updating Their Lupin Limited (NSE:LUPIN) Estimates After Its Annual Results

With EPS Growth And More, Lupin (NSE:LUPIN) Makes An Interesting Case

May 08
With EPS Growth And More, Lupin (NSE:LUPIN) Makes An Interesting Case

Investor Optimism Abounds Lupin Limited (NSE:LUPIN) But Growth Is Lacking

Apr 20
Investor Optimism Abounds Lupin Limited (NSE:LUPIN) But Growth Is Lacking

Here's Why Lupin (NSE:LUPIN) Can Manage Its Debt Responsibly

Mar 03
Here's Why Lupin (NSE:LUPIN) Can Manage Its Debt Responsibly

Earnings Beat: Lupin Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 10
Earnings Beat: Lupin Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Revenue & Expenses Breakdown

How Lupin makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NSEI:LUPIN Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24214,31326,26538,6640
30 Jun 24207,97122,63537,1960
31 Mar 24200,10819,14535,9300
31 Dec 23194,80117,91034,6470
30 Sep 23186,04913,31433,3940
30 Jun 23177,1199,71432,5040
31 Mar 23166,4174,30131,8450
31 Dec 22160,946-3,23931,0900
30 Sep 22159,33368230,8890
30 Jun 22158,791-21,59630,7580
31 Mar 22164,055-15,28030,8100
31 Dec 21163,052-5,49730,1510
30 Sep 21161,616-6,57029,7800
30 Jun 21159,05316,52129,0470
31 Mar 21151,63012,16529,1460
31 Dec 20152,26011,45830,3680
30 Sep 20149,777-1,60930,7070
30 Jun 20150,249-5,57231,4560
31 Mar 20153,748-3,99530,7440
31 Dec 19174,693-4,42835,4290
30 Sep 19176,8923,13834,9590
30 Jun 19172,8067,06834,3940
31 Mar 19146,6465,12129,6580
31 Dec 18163,114-4,66532,8750
30 Sep 18157,822-93131,7210
30 Jun 18157,82996031,0330
31 Mar 18157,7652,51330,7180
31 Dec 17159,23314,15030,3610
30 Sep 17164,30618,26430,7170
30 Jun 17167,69320,33630,5670
31 Mar 17173,67425,57530,4190
31 Dec 16173,91029,35128,2490
30 Sep 16164,55828,26526,3720
30 Jun 16154,91825,84124,5760
31 Mar 16141,31622,60722,9310
31 Dec 15131,05520,10636,5921,682
30 Sep 15127,27320,82335,4671,682
30 Jun 15125,79423,03534,6141,682
31 Mar 15127,70024,03218,5700
31 Dec 14128,12424,09232,7091,311
30 Sep 14126,56722,83932,3371,311
30 Jun 14121,51220,60131,6301,311
31 Mar 14112,86618,36430,8081,311

Quality Earnings: LUPIN has high quality earnings.

Growing Profit Margin: LUPIN's current net profit margins (12.3%) are higher than last year (7.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: LUPIN's earnings have grown significantly by 39.4% per year over the past 5 years.

Accelerating Growth: LUPIN's earnings growth over the past year (97.3%) exceeds its 5-year average (39.4% per year).

Earnings vs Industry: LUPIN earnings growth over the past year (97.3%) exceeded the Pharmaceuticals industry 22.3%.

Return on Equity

High ROE: LUPIN's Return on Equity (16.9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 18:26
End of Day Share Price 2025/02/07 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lupin Limited is covered by 75 analysts. 35 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nitin BhasinAmbit Capital
Prashant NairAmbit Capital
null nullAnand Rathi Shares and Stock Brokers Limited